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Abstract: Protection of Telomeres 1 (Pot1) is a protein that binds with high specificity and 
affinity to the single-stranded DNA overhang of telomeres in yeast and humans. Pot1 serves 
crucial functions in telomere regulation and in the protection of free telomere ends from 
catastrophic DNA damage responses. Ongoing research in the lab involves characterization 
of the fission yeast Schizosaccharomyces pombe Pot1 protein (SpPot1) as a means for 
understanding the mechanism of how Pot1 binds to telomeres. SpPot1 binds DNA through its 
DNA-binding domain (Pot1-DBD), which consists of two OB-fold subdomains, Pot1pN and 
Pot1pC. The interdomain interface between the two subdomains had been proposed to play 
an important role in shaping the specific binding of Pot1-DBD to telomeric DNA. 
Additionally, specific residues within the DNA-binding interface of Pot1pN were shown to 
play critical roles in Pot1-DBD DNA recognition. This thesis project aims to provide a more 
complete understanding of Pot1 binding by expanding upon studies of both the interdomain 
and DNA-binding interfaces. Previous data indicated that the interdomain interface makes a 
significant contribution to DNA binding under high salt conditions. Since salt concentration 
is known to affect some protein/DNA interactions, the role of the interface was investigated 
at low salt using specific alanine mutations. Binding studies indicated that the interface has 
no significant effect on binding at low salt, suggesting a complexity in the binding scheme of 
SpPot1, which is at least partially salt-dependent. Examination of DNA-binding activity was 
extended to the DNA-binding interface of Pot1pC. With no structural information available, 
systematic analysis of server-generated 3D models of Pot1pC was used to predict residues on 
the binding surface. Alanine mutants were constructed and circular dichroism was used to 
perform preliminary studies on the structure and stability of the free and DNA-bound mutant 
proteins compared to wild-type. The data revealed that, while secondary structures seem 
unaffected by the mutations or by DNA binding, Pot1pC displays an atypical melting curve, 
indicative of a conformational change during melting.  
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Introduction  
 Telomeres are nucleoprotein complexes composed of repetitive GT-rich DNA 
sequence located at the ends of eukaryotic linear chromosomes, which provide a buffer 
against the loss of genetic material from successive rounds of DNA replication.1 
Telomeres play other crucial roles in genome maintenance, as telomere destabilization 
can lead to human diseases such as cancer2, dyskeratosis congenital, aplastic anemia, and 
pulmonary fibrosis.3 Telomeric DNA sequence is species-specific4,5,6,7,8,  typically 
consisting of a long double-stranded DNA portion and ending with a shorter 3’ single-
stranded DNA (ssDNA) overhang. While this ssDNA overhang is crucial for telomere 
elongation and maintenance4, 9, it presents some problems for the cell. Unprotected 
telomeres can be recognized by the cell as damaged DNA and trigger DNA-damage 
responses, such as the ATM kinase signaling pathway (which responds to double-strand 
breaks) and the ATR kinase signaling pathway (which responds to single-stranded DNA) 
both of which can cause cell cycle arrest.10 In order to avoid this, cells cap the telomere 
ends with Telomere End-Protection (TEP) proteins that protect and regulate the ends of 
	  
Figure 1. Graphic representations of Pot1. A) Pot1 protein on 3’ telomere overhang. B) 
Representation of the Pot1 protein in context of the shelterin in Schizosaccharomyces 
pombe.13 C) Schematic of SpPot1. Pot1pN and Pot1pC make up Pot1-DBD.  	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eukaryotic chromosomes by directly binding to telomeric ssDNA.11 In fission yeast and 
humans, the capping protein is the Protection of Telomeres 1 (Pot1) protein (Figure 
1A).12 Pot1 is furthermore a part of the shelterin complex, a 6-protein complex localized 
to telomeres that provides not only protection of telomere ends but also positive and 
negative regulations of telomerase13, 14, the enzyme responsible for telomere elongation.15 
(Figure 1B). In fact, the binding of Pot1 itself is believed to take part in regulating the 
activity of telomerase.16, 17 Since the regulation of telomeres is related to aging18 and 
cancer2, the study of Pot1 binding to telomeric ssDNA is important.   
 This study aims to characterize certain aspects of the fission yeast 
Schizosaccharomyces pombe Pot1 (SpPot1) binding to ssDNA. The study of SpPot1 is 
important toward understanding human Pot1 (hPot1), since SpPot1 is similar to hPot1 in 
both the structure and specificity of binding.12 Both hPot1 and SpPot1 bind to ssDNA 
using an oligonucleotide-oligosaccharaide-binding fold (OB-fold) based DNA-binding 
domain (DBD) that is conserved in all structurally characterized TEP proteins, including 
Cdc13 of Saccharomyces cerevisiae19, TEBP of Oxytricha nova20,21, hPot122, and the N-
	  Figure	  2.	  Example	  of	  an	  OB-­‐fold.	  This	  particular	  one	  is	  from	  the	  N-­‐terminal	  OB-­‐fold	  of	  hPot1.11	  Note	  the	  beta-­‐barrel	  and	  the	  peripheral	  alpha	  helix	  and	  loops.	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terminal OB-fold of SpPot1 (Pot1pN)23. An OB-fold is characterized by a conserved C-
terminal alpha-helix, a five-stranded beta-barrel, and intervening loops which, along with 
the beta-strands, bind to oligonucleotides (Figure 2).24 Specifically, aromatic ring 
stacking, van der Waals, and hydrogen bonding interactions contribute to the ssDNA-
binding.25 Although the primary amino acid sequences for the SpPot1 and hPot1 proteins 
are only distantly conserved (23% identity between the structurally characterized OB-
folds in the two proteins and 10% identity in the rest of the proteins), this is typical of 
OB-folds25, and in fact, the structures of the N-terminal OB-fold of hPot1 (hPot1-OB1) 
and Pot1pN (the N-terminal OB-fold SpPot1) align quite well (Figure 3C).22,23  Each 
protein, however, has evolved for specific binding of the telomere sequence found within 
the organism.26,27 Both S. pombe and human telomeres consist of similar 6-nucleotide 
	  Figure	  3.	  Structurally	  characterized	  OB-­‐folds	  of	  human	  and	  S.	  pombe	  Pot1.	  A)	  Pot1pN,	  the	  N-­‐terminal	  OB-­‐fold	  of	  SpPot1.23	  B)	  The	  N-­‐terminal	  and	  C-­‐terminal	  OB-­‐folds	  comprising	  the	  DBD	  of	  hPot1.22	  The	  yellow	  structures	  in	  both	  (A)	  and	  (B)	  are	  the	  respective	  ssDNA	  to	  which	  the	  proteins	  bind.	  C)	  Structural	  alignment	  of	  Pot1pN	  with	  hPot1-­‐OB1.	  All	  pictures	  were	  made	  on	  Pymol.34	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repeat units, although with slightly different sequences, and with the inclusion of a 
variable spacer element in the S. pombe telomere. SpPot1 specifically binds to telomeric 
repeats of d(GGTTAC[N]0-8) with N being any nucleotide26, and hPot1 specifically binds 
to human telomeric repeats of d(TTAGGG).27 Therefore, hPot1 and SpPot1 are in fact 
homologs whose activities can be compared.12 
SpPot1 is crucial to S. pombe since its deletion leads to telomere loss, which is 
only rescued by chromosome circularization.12, 28 SpPot1 is composed of three domains: 
the structurally characterized OB-fold Pot1pN23, the predicted OB-fold Pot1pC5, which 
together make up the DNA-binding domain (Pot1-DBD), and an uncharacterized C-
terminal region25 (Figure 1C). Pot1pN is a 20.4 kDa protein with 177 residues9; Pot1pC 
is a 24.6 kDa domain composed of 212 residues29; Pot1-DBD is 389 residues with a 
molecular weight of 44.9 kDa25; and SpPot1 is 555 residues weighing 64.1 kDa.9 
Although Pot1pC has not been structurally characterized, it is predicted to have an OB-
fold for several reasons. It is known that the DBD of hPot1 contains two OB-folds (OB1 
and OB2) and that, as mentioned earlier, Pot1pN has an OB-fold which aligns well with 
hPot1-OB1, all of which bind DNA mainly through loop contacts as shown in Figure 3A 
and B.22,23 Therefore, it is likely that Pot1pC is structurally homologous to the hPot1-
OB2, especially since both Pot1pN and Pot1pC are known to bind to telomeric ssDNA.29 
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Previously, it has been shown that although the two domains Pot1pC and Pot1pN 
can independently bind to telomeric ssDNA repeats, in the context of Pot1-DBD, they do 
not bind additively as one might simply predict.29 The Pot1pN domain minimally binds a 
single telomere repeat, a 6mer of d(GGTTAC)9, and consistent with that interaction, 
Pot1-DBD minimally binds 2 repeats, a 12mer of d(GGTTACGGTTAC).25  From those 
data, it was expected that Pot1pC also binds to a 6mer repeat, but actually Pot1pC 
minimally binds 1.5 repeats, a 9mer of d(GGTTACGGT), indicating that the minimal 
binding of Pot1pN and Pot1pC are not additive to that of Pot1-DBD.25 To add to the 
complexity, it was further discovered that Pot1-DBD binds to the 12mer and the 15 
nucleotide composite sequence d(GGTTACGGTTACGGT) with similar affinity (Table 
1).25 Examination of the binding constants for the binding of Pot1-DBD to 12mer or 
15mer oligonucleotides revealed that its binding is also not thermodynamically additive 
	  
[NaCl]	  
(mM)	  
Oligonucleotide	  
sequence	  d(ssDNA)	   Binding	  constant	  (KD)	  
(nM)	   Free	  Energy	  (ΔG°’)	  of	  Binding	  Pot1pN	  	   50	   GGTTAC	  	   190	  	   8.5	  kcal/mol	  	  Pot1pC	  	   50	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  GGTTACGGT	  	   400	  	   8.1	  kcal/mol	  	  Pot1-­‐DBD25	   50	   GGTTACGGTTACGGT	  	   0.046	   13.1	  kcal/mol	  	  Pot1-­‐DBD	  	   400	   GGTTACGGTTACGGT	  	   0.12	   12.6	  kcal/mol	  	  Pot1-­‐DBD	  	   400	   GGTTACGGTTAC	   0.4	  	   11.9	  kcal/mol	  	  Pot1-­‐DBD_V97A	  	   400	   GGTTACGGTTACGGT	   0.046	   13.1	  kcal/mol	  	  Pot1-­‐DBD_V97A	  	   400	   GGTTACGGTTAC	  	   10	  	   10.1	  kcal/mol	  	  Pot1-­‐DBD_Q91A	  	   400	   GGTTACGGTTACGGT	   0.041	   13.2	  kcal/mol	  	  Pot1-­‐DBD_Q91A	  	   400	   GGTTACGGTTAC	   7	   10.3	  kcal/mol	  	  
Table 1.  Comparison of binding constants and their corresponding free energy for 
SpPot1 protein constructs binding to various oligonucleotide lengths.29 ∆G°’ is the 
biological standard free energy at 277.15K.  	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of the affinities of Pot1pN and Pot1pC for their respective minimal binding sequences.29 
Thermodynamic values are calculated for the Pot1pC (KD=190 nM)  and Pot1pC 
(KD=400 nM) using the equation ΔG°’ = −RTlnKD (Table 1), and if the binding is 
additive, ΔG°’ for Pot1-DBD is the sum of the two ΔG°’ values of the two domains such 
that ΔG°’ (Pot1-DBD) = ΔG°’ (Pot1pN) + ΔG°’ (Pot1pC).29  From these calculations, the 
theoretical value for the binding constant would be 80 fM at 50 mM NaCl.29 However, 
the actual binding constant for Pot1-DBD binding to 12mer at 50 mM NaCl is much 
weaker, at 46 pM (Table 1).25  This suggests that the binding of Pot1-DBD as a whole is 
more complex than just the addition of Pot1pN and Pot1pC. For clarification, the binding 
experiments for Pot1pN and Pot1pC were necessarily conducted at low salt (50 mM 
NaCl) because their binding affinities are too weak to be conducted at high salt (400 mM 
NaCl). On the other hand, binding affinities for Pot1-DBD and SpPot1 interactions are so 
tight that binding experiments are conducted at high salt in order to attenuate the binding, 
making data quantification more facile.  
Interestingly, further studies indicated that by disrupting the interaction between 
Pot1pN and Pot1pC, the binding affinity resembled more of how the additive binding of 
Pot1pN and Pot1pC might behave.29  The domain-domain interaction was disrupted by 
mutating residues on a putative DBD interdomain interface, which was deduced as the 
face of Pot1pN as shown in Figure 4 upon mapping of the minimal chemical shift 
perturbation (MCSP) data onto the crystal structure of Pot1pN (Figure 4).23,29  A 
significant degree of chemical shift changes were observed on a face distant from the 
DNA-binding interface, indicating the presence of an interdomain interaction surface.29 
On this putative DBD interdomain interface, mutations to alanine were made at the 
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residues V97 or Q91 in the context of Pot1-DBD (Figure 4).29 Binding studies revealed 
that these interdomain mutant proteins bind 3 times tighter to the 15mer oligonucleotide 
as compared to the wild-type Pot1-DBD (Table 1).29 This indicates that the interdomain 
mutants favor the additive scheme of the minimal binding sequence of Pot1pN (6mer) 
plus the minimal binding sequence of Pot1pC (9mer) more than the wild-type protein.29 
Additionally, the affinity of the mutants for 12mer became significantly weaker so that 
the mutant proteins exhibited a 250-fold difference in binding to 15mer than to 12mer, as 
compared to the 3-fold difference seen in wild-type (Table 1).29 The interdomain mutants 
thus seem to disfavor the nonadditive binding scheme of 12mer. Overall, this new 
preference for the 15mer indicates that the interaction between Pot1pN and Pot1pC at the 
DBD interdomain interface may have an important role in the binding of Pot1-DBD.29   
	  
Figure 4. The putative DBD interdomain interface on the surface of Pot1pN29. MCSP 
analysis shows the chemical shift difference between Pot1pN and the Pot1pN domain in 
the context of Pot1-DBD. The face lies opposite of the DNA-binding interface, as seen 
by the presence of the oligonucleotide on the other side. Colors show residues that have 
no MCSP difference (white), or MCSP differences that are weak (yellow), moderate 
(orange) or strong (red). The ssDNA is the 6mer sequence. 
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In addition to mutagenesis of the DBD interdomain interface, residue changes 
within the DNA-binding cleft were also seen to affect the binding activity of Pot1-DBD 
in previous studies.29 The structure of Pot1pN is known, including the residues involved 
in specifically binding to the 6mer (Figure 5A). Therefore, residues that are specifically 
involved in binding could be mutated within Pot1pN and Pot1-DBD. Then, the effects of 
the mutations were compared between Pot1pN binding to 6mer29 and Pot1-DBD binding 
to 12mer and 15mer (Sarah Altschuler, unpublished) (Figure 5B). The binding 
experiments were conducted at low salt in order to accommodate for the weak affinity of 
Pot1pN and to be able to make a comparison between Pot1-DBD and Pot1pN.29 The 
comparison showed that the same residues that affect Pot1pN binding also affect the 
binding of Pot1-DBD to 12mer, but less so in 15mer, as shown by the ΔΔG°’ (change in 
free energy of binding) values (Figure 5B). Therefore, Pot1pN interactions observed in 
the crystal structure seem to be conserved within the Pot1-DBD/12mer interaction, but 
	  
Figure 5. Alanine mutagenesis studies on the Pot1pN DNA-binding interface. A) 
Picture of the Pot1pN binding interface with colored residues involved in binding. B) 
Comparison of the difference in binding affinity of Pot1-DBD with 12mer and15mer 
(Sarah Altschuler, unpublished) and Pot1pN with 6mer29 when the binding residues are 
mutated.  All values were obtained at low salt (50 mM NaCl). 
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altered in the Pot1-DBD/15mer interaction (29; Sarah Altschuler, unpublished). Together, 
these studies begin to illustrate the more complete picture of how Pot1-DBD binds to 
ssDNA.  
The goals of this thesis project were to expand upon the previous studies on the 
interdomain interface and the binding interface, both of which aim to characterize the 
effects of specific residues of the S. pombe Pot1 on the DNA-binding activity. Toward 
this end, the first goal was to extend the examination of the DBD interdomain interface 
by thoroughly studying the effects of the interface in the context of SpPot1. The addition 
of the C-terminal region may significantly change the binding of SpPot1 from what is 
observed in just the Pot1-DBD. In addition to the two residues previously characterized, 
other residues on the DBD interdomain interface were also examined for a more 
complete understanding of the interface. Specifically, the effect of the DBD interdomain 
interface on SpPot1 binding was observed by mutating specific residues on the DBD 
interdomain interface in the context of SpPot1, and then by comparing the binding ability 
of the wild-type SpPot1 protein to the binding ability of the mutant SpPot1 proteins. The 
binding studies were conducted at low salt (50 mM NaCl) in order to be able to make a 
comparison to the low salt binding studies previously conducted on Pot1pN and Pot1pC.  
The second goal of this thesis involved examining the DNA-binding interface of 
Pot1pC in order to determine the effects of alterations within this domain, an extension of 
the work previously done with Pot1pN. Unlike Pot1pN, there is no structural data 
available for Pot1pC. Therefore, models of Pot1pC structure had to first be generated in 
order to predict the DNA-binding residues that could be further characterized by alanine 
mutagenesis. Then, after the stability and structure of mutant Pot1pC constructs are 
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affirmed by circular dichroism, the mutants could be tested in binding studies to see if 
they are involved in DNA binding. The effect of these mutants in the context of the 
whole binding domain (Pot1-DBD) was eventually to be investigated and compared to 
Pot1pC binding studies.  
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Figure 6. Schematics of the SpPot1 and Pot1pC expression constructs. A) Schematic of 
SpPot1 constructs, expressed with a N-terminal 10xHis-sumo tag. The two stars on the 
Pot1pN domain show where alanine mutations were made for the V97A 
(SpPot1_V97A) and P145A (SpPot1_P145A) mutants. B) Schematic of Pot1pC 
constructs with C-terminal intein/chitin binding domain. The two stars show where 
alanine mutations were made for the F65A (Pot1pC_F65A) and Y122A 
(Pot1pC_Y122A) mutants. 
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Methods 
Plasmid preparation. Site-directed mutagenesis was used to change certain amino acid 
sequences on the plasmid that encodes for the wild-type SpPot1 or Pot1pC to alanine. 
The mutagenesis was performed using the Quikchange II Site-Directed Mutagenesis Kit 
(Invitrogen), followed by cleanup. All the mutants were fully sequenced. The original 
plasmid for SpPot1 was a generous gift from Professor Thomas Cech. The SpPot1 vector 
is a pET-His-Smt3 vector that contains a Kanamycin-resistance gene and codes for 
10xHis-sumo tag on the N-terminus of SpPot1 (Figure 6A).30 The 10xHis-sumo tag can 
be cleaved off of the protein, once expressed, using ULP1 protease.30 The original 
plasmid for Pot1pC was available in the Wuttke laboratory. The Pot1pC vector is a 
pTXB1 vector (New England BioLabs) with Ampicillin resistance and contains Pot1pC    
C-terminally fused to an intein/chitin binding domain (Figure 6B). This intein/chitin 
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binding domain can be cleaved through intein-mediated self-cleavage upon addition of a 
reducing agent.31  
 
Pot1-DBD constructs. Pot1-DBD protein constructs were available in the laboratory, 
frozen at -80°C. These include wild-type Pot1-DBD and Pot1-DBD_V97A.29   
 
Expression and Purification of SpPot1. Three constructs of SpPot1 (wild-type SpPot1, 
SpPot1_V97A, and SpPot1_P145A) were expressed (Figure 6A). First, the SpPot1 
plasmid was transformed into and expressed in the Rosetta BL21(DE3) E.coli expression 
cell line. The E.coli were grown at 37°C in LB media with Kanamycin and 
Chloramphenicol (Rosetta resistance) to an OD600 of 0.5-1.2. Then the cells were placed 
on ice for an hour, at the end of which they were induced with 1 mM IPTG. The cells 
were then grown at 16 °C for 12-14 hours. Finally, the cells were spun down by 
centrifuge, collected, and frozen for later purification. The cell pellets were then thawed 
and resuspended in lysis buffer (500 mM NaCl, 20 mM Tris pH 8.4, 5 mM BME, 20 mM 
imidazole) on ice. The cells were treated with a protease inhibitor cocktail and additional 
PMSF, and then lysed by sonication. The soluble protein was separated from the cell 
debris through centrifugation. The supernatant, which contains the protein, was incubated 
batch-wise with Ni-charged beads (Qiagen) at 4 °C for 1 hour, during which the 10xHis-
sumo tag attached to the beads. The bound protein was washed with wash buffer (1 M 
NaCl, 75 mM imidazole, 20 mM Tris pH 8.4, 5 mM BME) to remove nonspecifically 
bound proteins, and then the protein was eluted off using the elution buffer (500 mM 
NaCl, 300 mM imidazole, 20 mM Tris pH 8.4, 5 mM BME). After concentrating this 
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eluate to <2 mL, the 10xHis-Sumo tag was cleaved off with ULP1 protein for 2 hours, 
spinning at 16,000xg at 4 °C, yielding untagged SpPot1 protein.30 The sample was further 
purified by Superdex S200 size exclusion chromatography (GE Healthcare) in buffer 
(500mM NaCl, 5mM DTT, 20mM Tris pH 8.4). The fractions containing the eluted 
protein were collected and concentrated to <500 µL, and then the sample was flash frozen 
in liquid nitrogen and stored at -80°C in 5 µL and 10 µL fractions. These processes 
ensured that pure samples of SpPot1 were obtained through both affinity and size-
exclusion chromatography. 
 
Expression and Purification of Pot1pC. Three Pot1pC constructs (wild-type Pot1pC, 
Pot1pC_F65A, and Pot1pC_Y122A) were expressed (Figure 6B). First, the plasmid was 
transformed into and expressed in BL21(DE3) E.coli expression cell line. The cells were 
grown at 37 °C in LB media with Ampicillin to an OD600 of 0.5-0.6. Then the cells were 
placed on ice for an hour, after which they were induced with 0.5 mM IPTG. The cultures 
were grown at 15 °C for 20 – 24 hours. After spinning down the cells by centrifuge, the 
cell pellets were collected and frozen. The cell pellets were thawed on ice. After 
resuspending them in lysis buffer (20 mM Tris pH 8.5, 500 mM NaCl) with protease 
inhibitor cocktail, the cells were lysed by sonication. A subsequent centrifugation 
separated soluble protein from cell debris. Upon adding PMSF to the supernatant, it was 
slowly poured through a chitin bead column (New England Biolabs) that had been pre-
equilibrated with lysis buffer, at 4 °C. After washing the column with lysis buffer, the 
beads were removed from the column and resuspended in lysis buffer containing 100 mM 
BME. The bead solution was incubated, unmoving, at 4 °C for 18 - 20 hours, in order to 
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allow intein-mediated self-cleavage of the protein, releasing untagged Pot1pC.31 The 
beads were then poured back onto the column, washed with lysis buffer, and the flow-
through and wash liquids were collected. The flow-through was concentrated to <2mL 
and purified by Superdex S75 size exclusion chromatography (GE Healthcare) in the 
final buffer (50 mM KPhos pH 8.0, 150 mM NaCl, 3 mM BME).  The fractions 
containing Pot1pC were collected and poured over a clean chitin bead column that had 
been pre-equilibrated with the final buffer in order to separate Pot1pC from any 
remaining cleaved intein/chitin binding domain. The flow-through was collected, along 
with the flow-through collected upon an additional wash of the column with the final 
buffer. The collected flow-through liquids were concentrated to 500-1000 µL and flash 
frozen by liquid nitrogen in appropriate aliquots. The samples were stored at -80°C.  
 
Activity correction for SpPot1. Electrophoretic mobility shift assay (EMSA) was used 
to calculate the active concentration of SpPot1, or the concentration of functional protein 
that actually binds to ssDNA. This was done by titrating a high concentration of ssDNA 
(100 nM nonradioactive DNA, plus 100 pM 32P-labeled DNA for quantification) with 
increasing amounts of SpPot1 protein, ranging from 0.5 pM – 2 µM diluted in low salt 
buffer (50 mM NaCl, 20 mM Tris pH 8.4, 15% glycerol, 5 mM BSA). The ssDNA was 
labeled with [γ-32P] ATP with T4 polynucleotide kinase (Invitrogen), and then 
unincorporated [γ-32P]-ATP was removed with a G25 spin column (GE Healthcare). The 
ssDNA and the protein were mixed together and allowed to bind for 30 minutes at 4 °C. 
Then the samples were loaded onto a 6.7% nondenaturing polyacrylamide gel made with 
1xTBE buffer (89 mM Trizma Base, 89 mM boric acid, 2 mM ethylenediaminetetraacetic 
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acid), and the gel was run in 1xTBE buffer with 5% glycerol at 4 °C, 200 V, for 20 
minutes. The gel was then dried under vacuum onto filter paper (Whatman) and scanned 
on a Typhoon Phosphorimager (GE Healthcare). Raw data from each binding experiment 
were quantified using ImageQuant (GE Healthcare) and converted to fraction bound for 
the determination of the active protein concentration. When the fraction of bound protein 
versus protein concentration was graphed using KaleidaGraph (Synergy Software), the 
inflection point showed the concentration at which the ratio of active protein to ssDNA is 
1:1. The correction value obtained from this assay was used to calibrate one preparation 
of protein from another as well as comparing the wild-type to the mutant SpPot1 
constructs.  
 
Electrophoretic mobility shift assay (EMSA). The binding assay for SpPot1 and Pot1-
DBD was almost identical to the activity assay, except that lower concentrations of 
ssDNA (1.5 pM) were used, so that the concentration is below the KD value, in order to 
prevent titration effects. Protein concentrations ranged from 0.005 pM to 2 µμM. Raw data 
from each binding experiment were quantified by phosphorimaging as described above, 
converted to fraction bound, and then globally fit using nonlinear curve regression to a 
standard two-state binding model where fraction bound = [PD]/[D]Total=[P]/([P]+KD), 
with P denoting protein and D denoting DNA. The fit was corrected by factors S and O 
such that fraction bound = S*[P]/([P]+KD) + O, from which the binding constant KD was 
calculated. For binding studies in Pot1-DBD, the quantification values were normalized 
to the background for optimal consistency. The binding constant for a particular protein 
construct was obtained from three independent EMSA experiments unless otherwise 
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noted. All error values are standard errors of the mean, generated from the global fit by 
KaleidaGraph.  
 
Generation of Pot1pC structural models. Online databases I-TASSER 
(http://zhanglab.ccmb.med.umich.edu/I-TASSER/)32 and LOMETS 
(http://zhanglab.ccmb.med.umich.edu/LOMETS/)33 were used to construct models of the 
Pot1pC structure. I-TASSER is a program that predicts protein structures from the 
primary sequence; for the Pot1pC modeling, the program threaded Pot1pC onto the 
requested PDB data using algorithms, alignment, low-energy predictions, and protein 
folding simulations.32 LOMETS(LOcal MEta-Threading Server) is a Meta-Threading-
Server, in which 8 threading programs, Fugue, HHsearch, Muster, PPA, ProSpect2, Sam-
T02, Sparks, and SP3, are used to give a structural prediction with the highest confidence 
scores.33 Pymol was used to visualize the models.34 
 
Circular Dichroism. Circular dichroism (CD) was used to assess the secondary structure 
and stability of Pot1pC protein constructs. The protein constructs were dialyzed into CD 
buffer (50 mM Na2SO4, 50 mM KPhos pH 8.0, 3 mM BME) using an overnight 
incubation in Slide-A-Lyzer Dialysis Cassette (2k molecular weight cut-off, 0.2-0.5 ml 
capacity) from Thermo Scientific. This step ensured that there were minimal amounts of 
chloride from the original buffer, as chloride absorbs in the far UV range.35 The dialyzed 
proteins were diluted to approximately 10 µM concentration in CD buffer and the spectra 
were taken from 210 nm to 260 nm in a 1mm path length cuvette on a Chirascan Plus 
Circular Dichroism Spectrometer (Applied Photophysics). For the spectra of the DNA-
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bound protein, Pot1pC was diluted into CD buffer with 10 µM of 9mer, 
d(GGTTACGGT). For the melting curve analysis, the CD spectra from 210 nm to 260 
nm were taken from 20°C to 80°C in approximately 5°C increments at 1 minute per time 
point, with a temperature increase rate of 1°C/min. The exact temperature of the solution 
was monitored and recorded using an in situ probe. All spectra were smoothed using 
Chirascan Prodata Viewer (Applied Photophysics) and graphed using KaleidaGraph. The 
circular dichroism in mdeg was normalized by conversion to mean residue ellipticity 
(mre) using mre = (mdeg)/[(protein concentration)(number of residues)] with units of 
[(cm2)(degrees)]/[(dmol)(number of residue)]. The wild-type Pot1pC for this CD study 
was obtained from the laboratory -80 °C stock, a generous gift of Sarah Altschuler and 
Thayne Dickey.  
 
Guanidine HCl denaturation analysis of the extinction coefficients of folded Pot1pC 
constructs. The unfolded extinction coefficients (the extinction coefficients calculated 
from primary sequence) were obtained for each construct using ExPasy ProtParam tool, 
where an algorithm is used to calculate the extinction coefficient at 280 nm using Tyr, 
Trp, and reduced Cys residues.36 While the extinction coefficient of the folded protein is 
the most useful for biochemical analysis, the folded extinction coefficient cannot be 
calculated in the same manner. Instead, it must be calculated by relating its absorbance to 
the absorbance and extinction coefficient of the unfolded protein through Beer’s law (A = εcl).  6 M GuHCl was added to each Pot1pC construct in its CD buffer (50 mM Na2SO4, 
50 mM KPhos pH 8.0, 3 mM BME) to denature and unfold them. The absorption reading 
at 280 nm was taken for both the folded and unfolded protein at the same concentration 
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diluted in CD buffer. The absorbance and concentration values were used to calculate the 
extinction coefficient of Pot1pC constructs in the folded state (equation discussed in 
results section). Three replicates for each construct were taken and averaged.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
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DBD interdomain interface 
Selection of DBD interdomain interface mutants. As an extension of the previous studies 
of the interdomain interface in Pot1-DBD conducted at high salt, studies were conducted 
on the interdomain interface of SpPot1. The SpPot1 studies were to be conducted at low 
salt, in order to be able to make comparison to the low salt binding studies conducted for 
Pot1pN and Pot1pC. Alanine mutations were made on the putative interdomain interface 
to observe the effect of the loss of interdomain interactions in the context of SpPot1. 
These residues were selected by examining the Pymol-generated surface of Pot1pN with 
respect to information available from the previous interdomain interface study.29 As a 
result, in addition to the previously studied Q91 and V97 residues, 8 more residues were 
chosen as good candidates for studies of the DBD interdomain interface (Figure 7). The 8 
residues (P54, S55, W65, K90, I98, P145, M148, P149) are located near Q91 and V97, 
indicating that these residues are likely to be part of the DBD interdomain interface. 
	  
Figure 7. Putative DBD interdomain interface surface of Pot1pN. The previously 
studied residues are labeled in red; the new candidates are labeled in green. Gray 
residues were found to have no MCSP change and black residues were found to be 
insoluble in the previous study.29 Pink residues have side chains pointing inside the 
protein. Modeled with Pymol.34 
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Additional information indicated that these residues are better candidates than other 
residues on the putative DBD interdomain interface. Mutations at certain residues were 
already known to produce insoluble proteins, and other residues had no MCSP change 
(Figure 7).29 Furthermore, structural analysis using Pymol indicated that some residues 
have side chains pointing inside the protein, making it less likely that they are involved in 
a domain-domain interaction.23,34  The chosen 8 residues are mostly unassigned by 
NMR29 and have outward side chains.23,34 Since this region is hypothesized as a flexible 
domain-domain interaction site, it is likely that some residues may be unassigned due to 
flexibility in the backbone.29 Three of the residues are unassigned because they are 
prolines, which cannot be assigned with conventional NMR experiments.29 However, two 
of the prolines chosen, P145 and P149, are contained within a PxPxP motif, which has 
been implicated in protein-protein interactions.37 The selected residues were mutated to 
alanine using site-directed mutagenesis, and the mutant and wild-type protein constructs 
of SpPot1 were expressed and purified for binding studies (Figure 8). Unfortunately, the 
SpPot1 constructs were difficult to express and purify, as shown in the size-exclusion 
chromatography (Figure 8A), as well as by the presence of a degradation product below 
the protein band on the SDS-PAGE gel (Figure 8B). For these reasons, these constructs 
were only used for preliminary studies, as will be discussed later. 
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Initial binding studies on SpPot1 mutants. Initially, three protein constructs wild-type 
(WT SpPot1), SpPot1_V97A, and SpPot1_P145A were compared for 15mer binding at 
50 mM NaCl, since in previous studies the interdomain mutants showed a significant 
preference for 15mer compared to wild-type. Upon conducting binding experiments by 
EMSA, typical binding curves were obtained for the three constructs (Figures 9A and 
9B). 
The activity corrections for the two mutants and the wild-type were taken in order 
to correct each protein for the active concentration of protein that actually binds to 
ssDNA. The activity correction thus allows for comparison between different protein 
samples by normalizing each protein sample to its effective concentration. This 
correction was done by titrating the protein constructs with a large fixed amount of 
	  
Figure 8. Purification of SpPot1 constructs. A) Size-exclusion chromatogram for the 
three constructs. The peak around 48 mL elution is the void, and the peak around 72 mL 
is the SpPot1 construct. B) SDS-PAGE gel for the final samples of the three constructs. 
Note the degradation product below the protein band. The gel bands are from different 
gels and at different concentrations but are aligned here for comparison. 
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ssDNA (15mer) (Figure 10A). In such a titration where the amount of ssDNA is greater 
than the binding constant, the point at which binding saturates (the inflection point on the 
titration curve) is the point at which the active concentration of protein is binding 1:1 
with the ssDNA (Figure 10B). This point was used to calculate the activity correction 
value and the active concentration of protein (Figure 10C). The corrected binding 
constants for the three constructs showed values that are within two-fold of each other, 
meaning that, under the low salt condition, there is no significant difference in the 
binding of the three constructs to 15mer (Figure 10C). Since these preliminary results 
suggested the possibility that there was a loss of mutant versus wild-type difference in 
binding at low salt, the study was shifted at this point to Pot1-DBD, in order to make a 
direct comparison to the original interdomain interface studies conducted with Pot1-DBD 
at high salt. 
	  
Figure 9. EMSA binding study for SpPot1 constructs. A) EMSA gel for the binding of 
the wild-type SpPot1, SpPot1_V97A, and SpPot1_P145A to 15mer at 50 mM NaCl. B) 
The sigmoidal curve from quantifying the three gels from (A). Protein concentrations 
range from 0.005 pM to 2 µM (0.005, 0.05, 0.2, 0.5, 2, 5, 20, 50, 200, 500, 2000, 5000, 
20000, 200000, 2000000 pM) 
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Confirmation of the low salt binding behavior in Pot1-DBD. In order to examine if 
similar salt-dependent loss of the interdomain effect on binding applied to the previously 
characterized Pot1-DBD mutants, studies were conducted on the Pot1-DBD_V97A 
mutant and wild-type Pot1-DBD at low salt. A single mutant (Pot1-DBD_V97A) was 
throughly studied at low salt, because previous work showed identical binding 
characteristic between the two mutants.29 The binding studies were conducted with both 
the 12mer and 15mer, since the difference in binding between 12mer and 15mer had 
previously distinguished the mutants from the wild-type at high salt (Figure 11A and 
11B). Specifically, comparison was made between 12mer and 15mer binding by Pot1-
	  
Figure 10. Activity correction and corrected binding constants for SpPot1 constructs. A) 
Titration curve for activity correction of SpPot1 binding, using 100 nM of 15mer. B) 
Zoomed-in graph for the squared portion of the wild-type curve from (A). The inflection 
values were averaged to give the raw activity correction value. This value was normalized 
by dividing by the concentration of ssDNA used. C) The activity correction values and the 
corrected KDs for the three SpPot1 constructs.  
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DBD_V97A and between the 12mer and 15mer of Pot1-DBD to see if the same 
preference of Pot1-DBD_V97A for 15mer is observed at low salt. Since the binding 
constants were compared within the same sample of protein, activity correction was not 
made. The wild-type Pot1-DBD bound to 12mer with a KD of  24 ± 2 pM and to 15mer 
with a KD of 18 ± 1 pM, which correspond to <2 fold difference in binding, meaning that 
the difference is insignificant (Figure 11C). In concensus with the preliminary studies in 
SpPot1,  Pot1-DBD_V97A also had a <2 fold difference between the binding of 12mer 
and 15mer (62 ± 4  pM and 44 ± 3 pM, respectively) (Figure 11C). The comparison 
shows that like the SpPot1 mutants, Pot1-DBD_V97A behaves much like wild-type and 
loses its preference for 15mer over 12mer at low salt. The results for the binding study of 
	  
Figure 11. Low salt binding study on 12mer and 15mer for wild-type Pot1-DBD and 
Pot1-DBD_V97A. A) Normalized binding curves for Pot1-DBD_V97A binding to 
12mer or 15mer. B) Normalized binding curves for WT Pot1-DBD binding to 12mer or 
15mer. C) Averaged binding constants for WT Pot1-DBD and Pot1-DBD_V97A. 
Comparisons are most usefully made within the same protein construct, since the binding 
constants were not corrected for activity.   
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SpPot1 and Pot1-DBD constructs are summarized in Table 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  
Table 2. Summary of the binding constants for SpPot1 and Pot1-DBD constructs. AThe 
values are corrected for activity, with no replicates. BThe values are uncorrected for 
activity and are an average of three replicates. 
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Pot1pC DNA-binding interface 
Designing Pot1pC mutants. In order to extend the study of the DNA-binding interface to 
Pot1pC, residues within the binding interface must be mutated for comparison with the 
wild-type Pot1pC. Since the structure of Pot1pC is as yet unknown, the study first 
required a prediction of the Pot1pC structure and its binding interface. The online servers 
LOMETS and I-TASSER were used to generate structural models of Pot1pC. LOMETS 
is a meta-server, which uses 8 programs to predict 3-D protein structures by threading the 
primary sequence of a protein onto known protein structures.33 I-TASSER, another online 
server, allows the user to input a structural template for threading.32 For Pot1pC structure 
prediction, the sequence was threaded onto the structurally characterized Pot1 OB-folds: 
Pot1pN, the N-terminal OB fold of hPot1 (OB1), and the C-terminal OB fold of hPot1 
(OB2).  
 Each of the 4 models shown in Figures 12B, C, D, E had the highest confidence 
scores (calculated by the server algorithm) of all the models provided by the particular 
server (Figures 12B, C, D, E). All four models were compared and assessed for 
commonly predicted features. Upon analysis, some of the models seemed to be more 
likely predictions for the structure of Pot1pC than others. Good models should have a C-
terminal alpha helix and 5-6 beta strands (structural characteristic of OB-folds24) (Figure 
2), a binding cleft created by beta-barrel and loops24 (Figure 12A), and reasonable, 
compact shapes. However, the LOMETS model for Pot1pC shows an incredibly long 
“tail” that did not thread onto any of the templates used by the LOMETS programs 
(Figure 12B). Pot1pC threaded onto hPot1-OB1 shows some improvement, yet the kink 
in the helix and the rather unstructured beta-barrel also make it a poor model (Figure 
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12C). Pot1pC threaded onto hPot1-OB2 and Pot1pC threaded onto Pot1pN show neither 
of those defects (Figures 12D, E). The model threaded onto Pot1pN is perhaps the “best” 
model because of the presence of what appears to be a binding cleft, although this visual 
assessment may not be accurate (Figure 12E). Finally, based on systematic assessment of 
the four models, five residues (Y47, F65, Y71, D118, and Y122) were chosen as good 
candidates for the binding interface study. Key features of these five residues make them 
good candidates. First, the five residues are found on the surface of all the models and are 
located on the beta-strands or on the intervening loops (color coded in Figures 12B, C, D, 
E). The five residues are mostly aromatic residues (tyrosine and phenylalanine), which 
are known to more often be involved in protein-ssDNA interactions in proteins with OB-
folds than other kinds of residues.11 An aspartate residue was also chosen because 
charged residues often take part in strong interactions with the oligonucleotides.11 Thus, 
the amino acids chosen were likely candidates as residues involved in ssDNA binding 
(Figures 12B, C, D, E).  
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Figure 12. Structural models for Pot1pC. A) Image of Pot1pN as an example of an 
OB-fold with a DNA-binding cleft. B) LOMETS model for Pot1pC specifically 
obtained from FUGUE program, utilizing hPot1 as the template.33 C) Pot1pC 
sequence threaded onto OB1 of hPot1 using I-TASSER.32 D) Pot1pC threaded onto 
the OB2 of hPot1.32 E) Pot1pC threaded onto Pot1pN.32 Residues that were chosen for 
mutagenesis studies are color coded such that Y47A is blue, F65A is orange, Y71A is 
black, D118A is red, and Y122A is pink. All pictures were made on Pymol.34  	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Confirmation of Pot1pC folding by circular dichroism (CD). Since the stability of the 
constructs is crucial to subsequent studies of Pot1pC binding, the Pot1pC constructs had 
to be first analyzed for structure conservation and stability using circular dichroism. 
Circular dichroism helps analyze the structure conservation between wild-type and 
mutant constructs by measuring the absorbance by secondary structures of proteins such 
as the alpha helix and beta-strands. Similarly, the structure conservation between the 
unbound construct and ssDNA-bound construct could also be observed. CD can also be 
used to analyze the stability of constructs by showing the degree to which the secondary 
structures of the protein change over a range of temperatures.38  
 The wild-type Pot1pC and two mutant constructs of Pot1pC (Pot1pC_F65A and 
Pot1pC_Y122A) were first expressed and purified. The purification of Pot1pC constructs 
	  
Figure 13. Purification of Pot1pC constructs. A) Size-exclusion chromatogram for three 
Pot1pC constructs. The largest peak around 69 mL of elution shows the peak for  
Pot1pC. B) SDS-PAGE gel for Pot1pC constructs after all purification steps. The 
samples are from different purifications and different gels and are at different 
concentrations but are aligned here for comparison. 
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was successful, with clean, single bands for each protein on the SDS-PAGE gel after 
purification (Figures 13A and B).  
 Following purification, the Pot1pC constructs were analyzed by CD to confirm 
and compare the secondary structures. Although the spectra below 210 nm could not be 
taken (due to high buffer absorbance below 210 nm), comparison of the wild-type (WT) 
Pot1pC with the Pot1pC_F65A and Pot1pC_Y122A showed that all three constructs 
seem to have similar alpha helix absorbance at around 222 nm (Figure 14A).39 The 
secondary structures of the three constructs bound to 9mer were also observed in order to 
see if DNA binding altered the protein conformation (Figure 14B). However, no evidence 
of significant folding upon binding was observed when the difference in mean residue 
ellipticity between bound and unbound constructs were plotted to scale (Figure 14C). 
Overall, whether unbound or bound, the mutant constructs seem to have secondary 
structures similar to wild-type, indicating that all three constructs are folded similarly. 
The minor differences in the magnitude of the spectra, despite corrections in converting 
the units to MRE (mean residue ellipticity), may be due to contamination accumulating in 
the CD cuvette per run, or due to inaccuracies in calculating concentrations, as will be 
discussed later. 
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Figure 14. Secondary structure analysis of Pot1pC constructs by CD. A) CD spectra in 
molar residue ellipticity (MRE) for the three Pot1pC constructs. MRE is in the units of 
(cm2 x deg)/(dmol x number of residues). B) CD spectra for the same three constructs 
bound in a 1:1 ratio to 9mer. C) The difference in MRE between bound and the unbound 
constructs (bound – unbound) graphed to the same scale as (A) and (B). D) Sample CD 
spectra for different secondary structures, for comparison and reference.39 	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The melting curves of the free and bound Pot1pC constructs were analyzed in 
order to observe the stability of the mutant constructs with respect to the wild-type 
(Figure 15). The temperature-dependent melting curves were made by graphing the alpha 
helical absorbance at 222 nm for all constructs with respect to the different temperatures 
(Figure 16). The wild-type and mutant constructs seemed to have similar stability, 
suggested by similar initial melting temperatures of 40 to 50 °C, as indicated by the shift 
in the secondary structure absorbance (Figure 15, 16). Between the unbound and bound 
states for each protein construct, the constructs also began melting at similar temperatures, 
so there did not seem to be an obvious destabilization or stabilization of protein by 
ssDNA binding (Figure 15, 16). Curiously, both the free and bound protein in all three 
constructs showed an initial increase in CD absorption signal and a shift toward the 218 
nm beta-strand absorption peak (the “dip” around 40 - 50°C), followed by a gradual 
decrease in signal as temperature increased (Figure 15).39 The Pot1pC_Y122A construct 
seemed to give the most pronounced behavior of this sort (Figure 15E, 15F, 16).  This 
unusual behavior may indicate an altered conformation of the protein at intermediate 
temperatures.  
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Figure 15. Melting curves as determined by CD. Melting curve for the free wild-type 
Pot1pC (A); wild-type Pot1pC bound to 9mer (B); free Pot1pC_F65A (C); 
Pot1pC_F65A bound to 9mer (D); free Pot1pC_Y122A (E); Pot1pC_Y122A bound 
to 9mer (F). 
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Determination of the extinction coefficient of Pot1pC constructs in the folded state. The 
difference in the absorptions of the Pot1pC constructs in Figures 14A and 14B, despite 
being corrected for concentration, indicated the necessity for a more careful analysis of 
the extinction coefficients (ε) at 280 nm. Accurate values for the extinction coefficients 
will also help obtain accurate binding constants in future EMSA studies. Extinction 
coefficient for the unfolded proteins can be estimated by the server-generated extinction 
coefficients, which are calculated from the absorbance of free amino acids in the primary 
sequence.36 However, extinction coefficients for the folded proteins cannot be obtained in 
this manner. Therefore, the extinction coefficients of the folded proteins must be 
calculated in comparison to the absorbance and the extinction coefficients of the unfolded 
	  
Figure 16. Single-wavelength melting curves at 222 nm (alpha helix absorbance) for the 
Pot1pC constructs. Note the common “dip” where the constructs begin melting around 
40-50 °C. 
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proteins. The extinction coefficients of the folded Pot1pC constructs were specifically 
calculated using (ε for folded construct)=(A280nm for folded)(ε for unfolded)/(A280nm for 
unfolded). The results showed that for each Pot1pC construct, the extinction coefficient 
for the folded state was somewhat higher than the extinction coefficient for the unfolded 
state (Table 3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pot1pC	  construct	   ε(unfolded),	  M-­‐1cm-­‐1	   ε(folded),	  M-­‐1cm-­‐1	   ε(folded)/	  ε(unfolded)	  Wild-­‐type	  Pot1pC	   34380	   36900	   1.07	  Pot1pC_F45A	   34380	   36500	   1.06	  Pot1pC_Y122A	   32890	   34200	   1.04	  
Table 3. Comparison of extinction coefficients for unfolded and folded Pot1pC 
constructs. Extinction coefficient increases for all three when they are folded. 
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Discussion 
DBD interdomain interface 
The DBD interdomain interface studies showed that although the interdomain 
mutants previously showed a preference for 15mer over 12mer at high salt, this 
preference is lost at low salt. Overall, at low salt, the mutants show binding activities 
similar to that of wild-type. This observation was first made in SpPot1 and then 
confirmed in Pot1-DBD constructs. Furthermore, other studies in the lab indicate that the 
low salt condition similarly affects the Pot1-DBD_Q91A mutant (Sarah Altschuler, 
unpublished).   
The results obtained from this study raise new questions about the interdomain 
interface and its effects on binding. The first question is what the binding behavior of the 
interface mutants will be at physiological salt, which can be closely approximated by 150 
mM NaCl.40 Neither 50 mM nor 400 mM salt gives an accurate depiction of cellular salt 
conditions. The experimental salt conditions are rather arbitrary and are related to the 
nature of the technique used in the binding studies, although 50 mM is the best salt 
condition for direct comparison with Pot1pN and Pot1pC, which bind very weakly to 
their respective ssDNA substrates at higher salt conditions. Although gel shift assays 
generally cannot be conducted with high salt concentrations, perhaps the current 
technique could be improved so that some salt can be tolerated. A new technique, which 
is not influenced by salt concentration, may also be explored.  
There may be several reasons explaining the observed salt dependence in the 
binding of the interdomain mutants to ssDNA. One reason may be that, although the 
interdomain interface mutants do in fact disrupt the interdomain interaction, the degree of 
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disruption is weak such that the effect can only be seen at high salt, where the high ionic 
strength disrupts interaction forces between the two domains. Another reason may be that 
the protein undergoes conformational changes between one salt concentration and 
another, in which the interdomain disruption has an effect in only one of the 
conformations.  
The second question is whether or not the putative interface studied in this assay 
is, in fact, the actual interdomain interface. Although NMR chemical shift data from 
studies on Pot1pN was used to hypothesize the location of the interdomain interface, 
perhaps the real interface is in other, uncharacterized regions of Pot1pN. Further 
mutagenesis studies may be conducted on other surfaces of Pot1pN in order to determine 
the location of an alternate interface. If the structures of Pot1pC and Pot1-DBD become 
available, they will greatly aid in the analysis. Another option is to compare the 
hypothesized DBD interdomain interface of SpPot1 to the DBD interdomain interface of 
hPot1, for which there is a structure.22,24 In fact, the interdomain interface of the hPot1 
structurally aligns34 with Pot1pN on a surface that is close but slightly off from the 
previously predicted interface (Figure 17B).  This face of Pot1pN may be a good 
candidate for future studies of the interdomain interface, especially since this potential 
putative interface includes flexible loop protrusions that may participate in domain-
domain interactions. 
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One may say that since the mutations did affect binding at high salt, then the 
putative interdomain interface is indeed the interface. However, it is possible that the 
mutations disrupted some other structural factor that affects binding.  In fact, although 
previously the linear relationship between salt concentration and KD had indicated a 
consistency in the binding mode of Pot1-DBD at different salt conditions, recent studies 
in the lab have suggested otherwise. The binding mode of SpPot1 and Pot1-DBD seems 
to be actually malleably altered at different salt conditions; salt has been seen to affect the 
preference of Pot1-DBD for each nucleotide position in its minimal binding sequence 
(Sarah Altschuler, Thayne Dickey; unpublished).  
 
 
 
	  
Figure 17. Two putative interdomain interfaces of SpPot1 on the Pot1pN surface. A) The 
putative interdomain interface, studied in this thesis project, based off of MCSP data.29 
B) The putative interdomain interface (cyan) predicted from the interdomain interface of 
hPot1 when Pot1pN is structurally aligned with hPot1-OB1. 22,23  
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Pot1pC mutant analysis 
Previous studies on the role of Pot1pN binding interface have provided valuable 
information about the binding of SpPot1 to ssDNA. Although the lack of a structure of 
Pot1pC made its study difficult, the aim was to extend the DNA-binding interface studies 
to Pot1pC. Predictions of Pot1pC structure using threading servers yielded models with 
OB-folds, which helped to hypothesize the location of the binding interface. However, 
prior to binding studies, circular dichroism had to be used in order to confirm that the 
mutant constructs maintained stability and structure comparable to wild-type. Preliminary 
analysis of the Pot1pC mutants by CD showed that the mutants have secondary structures 
similar to that of wild-type Pot1pC. Additionally, the binding of ssDNA to the constructs 
does not appear to affect folding. Reassuringly, the CD spectra observed for all constructs 
agree with data obtained for RPA-70, another OB-fold containing protein.41 The melting 
curve analysis by CD also showed that the wild-type and mutants have similar initial 
melting temperatures, and therefore they have similar stability. Curiously, however, all 
constructs showed atypical melting curves indicating altered conformations at 
intermediate temperatures.  
 At the current stage, the validity of the predicted binding interface mutants may 
be assessed through the comparison of Pot1pC models with the binding interface of the 
homologous hPot1-OB2. Examination of the hPo1-OB2 contact with ssDNA (Figure 3B) 
showed that hPot1-OB2 has a structural environment around the ssDNA that is somewhat 
atypical of OB-fold mediated binding by TEP proteins; the end portions of beta-barrel 
and alpha helices make contact with ssDNA, rather than the loops and the center of the 
beta-barrel involved in the typical binding cleft.22,24 Additionally, overlaying the server-
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predicted models of Pot1pC with hPot1-OB2 showed inconsistencies in residue 
composition. For example, in Pot1pC, one tyrosine of hPot1-OB2 overlays with a 
tryptophan, which is unseen in TEP-ssDNA binding interfaces.11,22 Tryptophans are, 
instead, seen to take part in the nonspecific binding of ssDNA by SSB.42  Also, a 
histidine involved in ring-stacking in hPot1-OB2 overlays with an arginine which is not a 
ring, although arginine could take part in a pi-cation interaction with aromatic rings. 22,43 
In sum, although the binding residues for the Pot1pC models in this study were predicted 
using the typical TEP binding characteristics, the rather atypical overlay with hPot1-OB2 
indicates that the actual binding mode of Pot1pC may be unique.  If the structure of 
Pot1pC becomes solved, that would allow structure-directed analysis from the confirmed 
DNA-binding interface of Pot1pC, and also show whether the threading and modeling 
processes used in this study are accurate or not. 
The CD analysis of Pot1pC constructs have also brought up interesting ideas that 
could be further investigated. For instance, the curious behavior of the melting curves of 
the Pot1pC constructs could be explained by one hypothesis. The protein may be 
experiencing an initial unfolding of the predicted alpha helical structure, leading to the 
loss of the alpha helical double peaks at around 208 nm and 222 nm.39 The beta-barrel 
core of the OB-fold may be more stable than the alpha helices and thus remain folded. 
During this time, a conformational change also occurs in which beta-strand structure 
actually increases. At higher temperatures, the beta-barrel slowly unfolds, leading to the 
loss in its absorbance signal. Further studies will need to be conducted in order to validate 
or reject this hypothesis, and to see whether the phenomenon is common to all OB-folds.  
This hypothesis can be tested by conducting melting curve analysis on other proteins that 
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are known to have OB-folds, such as Pot1pN, Cdc13, and hPot1, all of which are 
available in the lab. Furthermore, the buffering conditions used for CD could be 
improved so that regions below 210 nm can be observed without the level of noise seen 
in this study. This would allow for clearer observation of the second alpha helix peak at 
208 nm, which would provide more valuable information about the protein’s secondary 
structure.  
Furthermore, during the Pot1pC study, it was shown that the extinction 
coefficients of the folded Pot1pC constructs are higher than that of the unfolded Pot1pC 
constructs. This behavior is consistent with what was previously seen in the lab for the 
extinction coefficients of unfolded and folded Pot1-DBD, as well as with at least one 
literature work on the difference in extinction coefficients of amino acids between the 
folded and unfolded states.44   
Importantly, this Pot1pC study has set the foundations for studying the larger 
question of what the role of Pot1pC is in the context of Pot1-DBD. Once the mutant 
Pot1pC constructs are tested for binding with 9mer, those residues mutations that disrupt 
binding with respect to the wild-type (and therefore more likely to be a part of the 
binding interface) could then be tested in the context of Pot1-DBD. Then, through 
binding studies similar to the Pot1pN study, the contribution of the binding residues in 
the context of Pot1pC with 9mer could be compared to that of Pot1-DBD with 12mer and 
with 15mer. Together, the Pot1pN and Pot1pC binding interface studies could elucidate 
on the binding scheme of Pot1-DBD with respect to its independent domains.  
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Conclusion 
 The work presented here has contributed to the characterization of SpPot1 binding 
to ssDNA. First, investigation of the DBD interdomain interface showed that the 
hypothesized DBD interdomain interface has a potentially salt-dependent role in the 
binding of SpPot1 to ssDNA. The mainly spectroscopic studies of the Pot1pC domain 
hint at an interesting structural characteristic of Pot1pC and the possibility of altered 
conformations at different conditions. Data obtained from these Pot1pC studies may 
provide useful preliminary data for future studies related to the role of the Pot1pC 
binding interface as well as SpPot1 as a whole. In sum, although there are many more 
experiments that must be conducted in order to obtain a full understanding of SpPot1 
binding, the studies presented here contribute to the understanding of an important 
protein, Pot1.  
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